Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not-amyloid in cognitively normal older individuals

Journal of Neuroscience

Volumn 33, Issue 13, 2013, Pages 5553-5563

  Wirth, Miranka ^a   Madison, Cindee M ^a   Rabinovici, Gil D ^a,b,c   Oh, Hwamee ^a   Landau, Susan M ^a,b   Jagust, William J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; INFORMATION PROCESSING; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID; ANALYSIS OF VARIANCE; ANILINE COMPOUNDS; BIOLOGICAL MARKERS; BRAIN MAPPING; COGNITION DISORDERS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; REPRODUCIBILITY OF RESULTS; THIAZOLES;

EID: 84875423094     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4409-12.2013     Document Type: Article

References (78)

1. Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SK, James JA, Snitz BE, Houck PR, Bi W, Cohen AD, Lopresti BJ, DeKosky ST, Halligan EM, Klunk WE (2008) Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65:1509-1517. CrossRef Medline
2. Ashburner J, Friston K (1997) Multimodal image coregistration and partitioning-a unified framework. Neuroimage 6:209-217. CrossRef Medline
3. Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, Putcha D, Fischl B, Greve DN, Marshall GA, Salloway S, Marks D, Buckner RL, Sperling RA, Johnson KA (2011) Amyloid-beta associated cortical thinning in clinically normal elderly. Ann Neurol 69:1032-1042. CrossRef Medline
4. Benton AL, Hamsher K, Sivan AB (1983) Multilingual aphasia examination. Iowa City, IA: University of Iowa.
5. Chételat G, Villemagne VL, Villain N, Jones G, Ellis KA, Ames D, Martins RN, Masters CL, Rowe CC (2012) Accelerated cortical atrophy in cognitively normal elderly with high beta-amyloid deposition. Neurology 78:477-484. CrossRef Medline
6. Cohen J, Cohen P (1975) Applied multiple regression/correlation analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum.
7. Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I: segmentation and surface reconstruction. Neuroimage 9:179-194. CrossRef Medline
8. Deary IJ (2000) Looking down on human intelligence: from psychometrics to the brain. New York: Oxford UP.
9. de Calignon A, Polydoro M, Suárez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, Pitstick R, Sahara N, Ashe KH, Carlson GA, Spires-Jones TL, Hyman BT (2012) Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73:685-697. CrossRef Medline
10. Delis DC, Kramer JH, Kaplan E, Ober BA (2000) California verbal learning test, Ed 2. San Antonio, TX: Psychological Corporation.
11. den Heijer T, Geerlings MI, Hoebeek FE, Hofman A, Koudstaal PJ, Breteler MM (2006) Use of hippocamal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch Gen Psychiatry 63:57-62. CrossRef Medline
12. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968-980. CrossRef Medline
13. Desikan RS, McEvoy LK, Thompson WK, Holland D, Brewer JB, Aisen PS, Sperling RA, Dale AM (2012) Amyloid-beta-associated clinical decline occurs only in the presence of elevated P-tau. Arch Neurol 69:709-713. CrossRef Medline
14. Dickerson BC, Wolk DA (2012) MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology 78:84-90. CrossRef Medline
15. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, Fischl B, Buckner RL (2009) The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 19:497-510. CrossRef Medline
16. Dickerson BC, Stoub TR, Shah RC, Sperling RA, Killiany RJ, Albert MS, Hyman BT, Blacker D, Detoledo-Morrell L (2011) Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 76:1395-1402. CrossRef Medline
17. Field AP (2005) Discovering statistics using SPSS: and sex, drugs and rock 'n' roll, Ed 2. London: Sage.
18. Fischl B, Dale AM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 97: 11050-11055. CrossRef Medline
19. Fischl B, Sereno MI, Dale AM (1999a) Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. Neuroimage 9:195-207. CrossRef Medline
20. Fischl B, Sereno MI, Tootell RB, Dale AM (1999b) High-resolution inter-subject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 8:272-284. CrossRef Medline
21. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341-355. CrossRef Medline
22. Fjell AM, Walhovd KB, Reinvang I, Lundervold A, Salat D, Quinn BT, Fischl B, Dale AM (2006) Selective increase of cortical thickness in high-performing elderly-structural indices of optimal cognitive aging. Neuro-image 29:984-994. CrossRef Medline
23. Fjell AM, Westlye LT, Amlien I, Espeseth T, Reinvang I, Raz N, Agartz I, Salat DH, Greve DN, Fischl B, Dale AM, Walhovd KB (2009) High consistency of regional cortical thinning in aging across multiple samples. Cereb Cortex 19:2001-2012. CrossRef Medline
24. Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM (2010a) CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. J Neurosci 30:2088-2101. CrossRef Medline
25. Fjell AM, Amlien IK, Westlye LT, Stenset V, Fladby T, Skinningsrud A, Eilsertsen DE, Bjørnerud A, Walhovd KB (2010b) CSF biomarker pathology correlates with a medial temporo-parietal network affected by very mild to moderate Alzheimer's disease but not a fronto-striatal network affected by healthy aging. Neuroimage 49:1820-1830. CrossRef Medline
26. Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Blennow K, Brewer JB, Dale AM (2010c) Brain atrophy in healthy aging is related to CSF Levels of A beta 1-42. Cereb Cortex 20: 2069-2079. CrossRef Medline
27. Folstein M, Folstein S, McHugh P (1975) "Mini-mental state": a practical method for grading the cognitive state of patients for the clinicians. J Psychiatric Res 12:189-198. CrossRef Medline
28. Hedden T, Gabrieli JD (2004) Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 5:87-96. CrossRef Medline
29. Heister D, Brewer JB, Magda S, Blennow K, McEvoy LK (2011) Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology 77:1619-1628. CrossRef Medline
30. Herrup K (2010) Reimagining Alzheimer's disease: an age-based hypothesis. J Neurosci 30:16755-16762. CrossRef Medline
31. Hulshoff Pol HE, Schnack HG, Posthuma D, Mandl RC, Baare WF, van Oel C, van Haren NE, Collins DL, Evans AC, Amunts K, Burgel U, Zilles K, de Geus E, Boomsma DI, Kahn RS (2006) Genetic contributions to human brain morphology and intelligence. J Neurosci 26:10235-10242. CrossRef Medline
32. Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, Whitewell JL, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, et al. (2008) The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27:685-691. CrossRef Medline
33. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9:119-128. CrossRef Medline
34. Jack CR Jr, Knopman DS, Weigand SD, Wiste HJ, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts RO, Rocca WA, Boeve BF, Petersen RC (2012) An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol 71:765-775. CrossRef Medline
35. Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA (2010) The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement 6:221-229. CrossRef Medline
36. Joshi A, Koeppe RA, Fessler JA (2009) Reducing between scanner differences in multi-center PET studies. Neuroimage 46:154-159. CrossRef Medline
37. Karama S, Ad-Dab'bagh Y, Haier RJ, Deary IJ, Lyttelton OC, Lepage C, Evans AC (2009) Positive association between cognitive ability and cortical thickness in a representative US sample of healthy 6 to 18 year-olds. Intelligence 37:145-155. CrossRef Medline
38. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55:306-319. CrossRef Medline
39. Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts RO, Boeve BF, Petersen RC (2012) Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease. Neurology 78:1576-1582. CrossRef Medline
40. Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32:1207-1218. CrossRef Medline
41. Leritz EC, Salat DH, Williams VJ, Schnyer DM, Rudolph JL, Lipsitz L, Fischl B, McGlinchey RE, Milberg WP (2011) Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults. Neuroimage 54:2659-2671. CrossRef Medline
42. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. Cereb Blood Flow Metab 16:834-840.
43. Medline Luders E, Narr KL, Thompson PM, Toga AW (2009) Neuroanatomical correlates of intelligence. Intelligence 37:156-163. CrossRef Medline
44. Mathalon DH, Sullivan EV, Rawles JM, Pfefferbaum A (1993) Correction for head size in brain-imaging measurements. Psychiatry Res 50:121-139. CrossRef Medline
45. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:263-269. CrossRef Medline
46. Mesulam MM (1999) Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 24:521-529. CrossRef Medline
47. Metz CE (1978) Basic principles of ROC analysis. Sem Nucl Med 8:283-298. CrossRef Medline
48. Minoshima S, Frey KA, Foster NL, Kuhl DE (1995) Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 19:541-547. CrossRef Medline
49. Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC (2006) [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 67:446-452. CrossRef Medline
50. Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ (2009) Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 132:1310-1323. CrossRef Medline
51. Mormino EC, Brandel MG, Madison CM, Rabinovici GD, Marks S, Baker SL, Jagust WJ (2012) Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage 59:1152-1160. CrossRef Medline
52. Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412-2414. Medline
53. Morris JC, Roe CM, Grant EA, Head D, Storandt M, Goate AM, Fagan AM, Holtzman DM, Mintun MA (2009) Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Arch Neurol 66:1469-1475. CrossRef Medline
54. Oh H, Mormino EC, Madison C, Hayenga A, Smiljic A, Jagust WJ (2011) Beta-Amyloid affects frontal and posterior brain networks in normal aging. Neuroimage 54:1887-1895. CrossRef Medline
55. Oh H, Madison C, Haight TJ, Markley C, Jagust WJ (2012) Effects of age and beta-amyloid on cognitive changes in normal elderly people. Neurobiol Aging 33:2746-2755. CrossRef Medline
56. Oishi K, Akhter K, Mielke M, Ceritoglu C, Zhang J, Jiang H, Li X, Younes L, Miller MI, van Zijl PC, Albert M, Lyketsos CG, Mori S (2011) Multimodal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease. Front Neurol 2:54. CrossRef Medline
57. Park HJ, Lee JD, Chun JW, Seok JH, Yun M, Oh MK, Kim JJ (2006) Cortical surface-based analysis of 18F-FDG PET: measured metabolic abnormalities in schizophrenia are affected by cortical structural abnormalities. Neuroimage 31:1434-1444. CrossRef Medline
58. Perrin RJ, Fagan AM, Holtzman DM (2009) Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461:916-922. CrossRef Medline
59. Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC (2007) Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 130:2837-2844. CrossRef Medline
60. Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, Holt DP, Meltzer CC, DeKosky ST, Mathis CA (2005) Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. Cereb Blood Flow Metab 25:1528-1547. CrossRef Medline
61. Quigley H, Colloby SJ, O'Brien JT (2011) PET imaging of brain amyloid in dementia: a review. Int J Geriatr Psychiatry 26:991-999. CrossRef Medline
62. Raz N, Rodrigue KM (2006) Differential aging of the brain: patterns, cognitive correlates and modifiers. Neurosci Biobehav Rev 30:730-748. CrossRef Medline
63. Raz N, Gunning-Dixon F, Head D, Rodrigue KM, Williamson A, Acker JD (2004) Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: replicability of regional differences in volume. Neurobiol Aging 25:377-396. CrossRef Medline
64. Reitan RM (1958) Validity of the trailmaking test as an indication of organic brain damage. Percept Mot Skills 8:271-276. CrossRef
65. Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, et al. (2010) Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31: 1275-1283. CrossRef Medline
66. Ségonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, Fischl B (2004) A hybrid approach to the skull stripping problem in MRI. Neuroimage 22:1060-1075. CrossRef Medline
67. Shaw LM (2008) PENN biomarker core of the Alzheimer's Disease Neuroimaging Initiative. Neurosignals 16:19-23. CrossRef Medline
68. Small SA, Duff K (2008) Linking A beta and Tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 60:534-542. CrossRef Medline
69. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:280-292. CrossRef Medline
70. Storandt M, Mintun MA, Head D, Morris JC (2009) Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Arch Neurol 66:1476-1481. CrossRef Medline
71. Storandt M, Head D, Fagan AM, Holtzman DM, Morris JC (2012) Toward a multifactorial model of Alzheimer disease. Neurobiol Aging 33:2262-2271. CrossRef Medline
72. Trenerry MR, Crosson B, DeBoe J, Leber WR (1989) Stroop Neuropsychological Screening Test Manual. Odessa, FL: Psychological Assessment Resources.
73. Wechsler D (1987) Manual for Wechsler memory scale, revised. San Antonio, TX: Psychological Corporation.
74. Wechsler D (1997a) Wechsler memory scale: administration and scoring manual, Ed 3. San Antonio, TX: Psychological Corporation.
75. Wechsler D (1997b) Wechsler adult intelligence scale: administration and scoring manual, Ed 3. San Antonio, TX: Psychological Corporation.
76. Wirth M, Oh H, Mormino EC, Markley C, Landau SM, Jagust W (2013) The effect of beta-amyloid on longitudinal cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimers Dement, in press.
77. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatric Res 17:37-49. CrossRef Medline
78. Zhang D, Wang Y, Zhou L, Yuan H, Shen D (2011) Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage 55:856-867. CrossRef Medline